Accurate risk estimation of β‐amyloid positivity to identify prodromal Alzheimer's disease: Cross‐validation study of practical algorithms
Abstract
The aim was to create readily available algorithms that estimate the individual risk of β‐amyloid (Aβ) positivity.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 23, 2018
- Source ID
- 10.1016/j.jalz.2018.08.014
Entities
People
- Britta Brix
- Erik Stomrud
- Henrik Zetterberg
- Kaj Blennow
- Niklas Mattsson
- Oskar Hansson
- Philip S Insel
- Sebastian Palmqvist
- The Alzheimer’s Disease Neuroimaging Initiative*
- The Swedish Biofinder Study
Organizations
- EUROIMMUN Medizinische Labordiagnostika AG (Germany)
- Hjärnfonden
- Lund University
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- Sahlgrenska University Hospital
- Skåne University Hospital
- Swedish Research Council
- United States Department of Defense
- University College London